PlainRecalls
FDA Drug Moderate Class II Terminated

Liothyronine Sodium Tablets, USP, 25 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191,(U.T. of D & NH), India. NDC 62756-590-88

Reported: November 8, 2023 Initiated: October 20, 2023 #D-0084-2024

Product Description

Liothyronine Sodium Tablets, USP, 25 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191,(U.T. of D & NH), India. NDC 62756-590-88

Reason for Recall

Failed Impurities/Degradation Specifications.

Details

Units Affected
2304 Bottles
Distribution
Nationwide within the United States
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Liothyronine Sodium Tablets, USP, 25 mcg, 100-count bottles, Rx only, Distributed by: Sun Pharmaceutical Industries, Inc.Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191,(U.T. of D & NH), India. NDC 62756-590-88. Recalled by SUN PHARMACEUTICAL INDUSTRIES INC. Units affected: 2304 Bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 8, 2023. Severity: Moderate. Recall number: D-0084-2024.